Literature DB >> 34531156

Indoor air pollution exposure is associated with greater morbidity in cystic fibrosis.

Sara W Carson1, Kevin Psoter2, Kirsten Koehler3, Karen R Siklosi4, Kristina Montemayor5, Alexandra Toporek5, Natalie E West5, Noah Lechtzin5, Nadia N Hansel5, Joseph M Collaco4, Christian A Merlo6.   

Abstract

BACKGROUND: Exposure to higher levels of outdoor air pollution is associated with increased morbidity in individuals with cystic fibrosis. Limited information exist regarding the potential adverse effects of indoor air pollution on those with cystic fibrosis.
METHODS: Individuals with cystic fibrosis who were enrolled in the Twin and Sibling Study from 2000-2013, self-reported exposure to four known sources of indoor air pollution (secondhand smoke, forced hot air, wood stove and fireplace). Change in lung function, rates of hospitalizations and pulmonary exacerbations were followed over 4 years to compare outcomes in those who were exposed to those who were not exposed.
RESULTS: Of 1432 participants with data on secondhand smoke exposure, 362 (25.3%) were exposed. Of 765 individuals with data on forced hot air exposure, 491 (64.2%) were exposed. Of 1247 participants with data on wood stove exposure and 830 with data on fireplace exposure, 182 (14.6%) and 373 (44.9%) were exposed, respectively. In longitudinal analysis, pediatric individuals either exposed to secondhand smoke or to forced hot air had a 0.60% predicted/year decrease in FEV1% predicted (P=0.002) or a 0.46% predicted/year decrease in FEV1% predicted (P=0.048), respectively compared to individuals who were not exposed. Adults exposed to secondhand smoke had a 42% increased yearly risk of hospitalization compared to those who were not exposed (P=0.045).
CONCLUSIONS: Our questionnaire-based data suggest that exposure to sources of indoor air pollution increase morbidity in both the pediatric and adult cystic fibrosis populations. Future studies with quantitative indoor air quality assessments are needed.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Indoor air quality; Obstructive lung disease; Secondhand smoke

Mesh:

Substances:

Year:  2021        PMID: 34531156      PMCID: PMC8918065          DOI: 10.1016/j.jcf.2021.08.015

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  28 in total

1.  Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa.

Authors:  Noah Lechtzin; Majnu John; Rafael Irizarry; Christian Merlo; Gregory B Diette; Michael P Boyle
Journal:  Respiration       Date:  2005-08-17       Impact factor: 3.580

2.  The National Human Activity Pattern Survey (NHAPS): a resource for assessing exposure to environmental pollutants.

Authors:  N E Klepeis; W C Nelson; W R Ott; J P Robinson; A M Tsang; P Switzer; J V Behar; S C Hern; W H Engelmann
Journal:  J Expo Anal Environ Epidemiol       Date:  2001 May-Jun

3.  Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis.

Authors:  Kaïssa de Boer; Katherine L Vandemheen; Elizabeth Tullis; Steve Doucette; Dean Fergusson; Andreas Freitag; Nigel Paterson; Mary Jackson; M Diane Lougheed; Vijay Kumar; Shawn D Aaron
Journal:  Thorax       Date:  2011-06-15       Impact factor: 9.139

4.  Higher risk of hospitalization among females with cystic fibrosis.

Authors:  Anne Stephenson; Janet Hux; Elizabeth Tullis; Peter C Austin; Mary Corey; Joel Ray
Journal:  J Cyst Fibros       Date:  2010-12-04       Impact factor: 5.482

5.  Identifying treatments that halt progression of pulmonary disease in cystic fibrosis.

Authors:  P B Davis; P J Byard; M W Konstan
Journal:  Pediatr Res       Date:  1997-02       Impact factor: 3.756

6.  Decline in lung function does not predict future decline in lung function in cystic fibrosis patients.

Authors:  Margaret Rosenfeld; Donald R VanDevanter; Clement L Ren; Eric P Elkin; David J Pasta; Michael W Konstan; Wayne J Morgan
Journal:  Pediatr Pulmonol       Date:  2015-06-18

7.  In-home air pollution is linked to respiratory morbidity in former smokers with chronic obstructive pulmonary disease.

Authors:  Nadia N Hansel; Meredith C McCormack; Andrew J Belli; Elizabeth C Matsui; Roger D Peng; Charles Aloe; Laura Paulin; D'Ann L Williams; Gregory B Diette; Patrick N Breysse
Journal:  Am J Respir Crit Care Med       Date:  2013-05-15       Impact factor: 21.405

8.  Risk factors for rate of decline in FEV1 in adults with cystic fibrosis.

Authors:  Michael W Konstan; Jeffrey S Wagener; Donald R Vandevanter; David J Pasta; Ashley Yegin; Lawrence Rasouliyan; Wayne J Morgan
Journal:  J Cyst Fibros       Date:  2012-05-05       Impact factor: 5.482

9.  Impact of air pollution on cystic fibrosis pulmonary exacerbations: a case-crossover analysis.

Authors:  Pieter C Goeminne; Michał Kiciński; François Vermeulen; Frans Fierens; Kris De Boeck; Benoit Nemery; Tim S Nawrot; Lieven J Dupont
Journal:  Chest       Date:  2013-04       Impact factor: 9.410

10.  The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry.

Authors:  Emily A Knapp; Aliza K Fink; Christopher H Goss; Ase Sewall; Josh Ostrenga; Christopher Dowd; Alexander Elbert; Kristofer M Petren; Bruce C Marshall
Journal:  Ann Am Thorac Soc       Date:  2016-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.